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Patients who undergo a total abdominal hysterectomy (TAH) experience a 
significant amount of pain postoperatively.  Several multimodal pain regimes have 
been used in the past to manage these women’s pain.  Neuraxial anaesthesia is 
usually not a feasible option in these cases, because of the risks involved.  Limited 
resources with the lack of high care unit beds available when intrathecal opioids are 
given are also a problem.  Effective analgesia includes both improved comfort and 
decreased opiate side-effects, if morphine requirements can be decreased. 
 
After approval from the University of Cape Town Human Research Ethics 
Committee, the trial was registered with the South African National Clinical Trial 
Register (DOH-27-0212-3945) and the South African National Human Research 
Ethics Council.  All patients between the ages of 20-65 with an ASA score I-III were 
included in a prospective double-blind randomised controlled trial after obtaining 
written informed consent from them the day before their operation. 
 
Patients were excluded if they were allergic to any of the trial medication 
(morphine,bupivacaine), had a history of opioid addiction, coagulation disorders, 
infection at needle insertion site or were unable to give informed consent.  If surgery 
did not for some reason proceed to a TAH, the patient was also excluded. 
 
The patients were visited in the ward the day before their operation to obtain 
informed consent.  All the patients received a patient-controlled analgesia (PCA) 
pump and this as well as the visual analogue pain scale (VAS) were demonstrated 
and explained to them.  This was done by the same person (principle investigator) 
for all the patients.  
 
Our aim with this double-blind randomised controlled trial was to study the efficacy 
of ultrasound-guided transversus abdominis plane blocks in patients undergoing 
total abdominal hysterectomy.  We randomly allocated thirty patients to two groups, 
a transversus abdominis plane block group (n=15) and a placebo group (n=15).  The 
transversus abdominis plane blocks were done with 0.25% bupivacaine.  The 
placebo group received a sham block with normal saline post induction of 
anaesthesia.  All patients received postoperative morphine patient-controlled 
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analgesia.  Pain scores and morphine consumption were assessed at 0, 6 and 24 
hours postoperatively.   
 
Our trial showed a significant between-group difference in morphine requirements 
(5.2±3.9 vs. 9.7±4.3 mg [p=0.007], and 12.9±8.9 mg vs. 25±12.1 [p=0.006]) for the 
transversus abdominis plane- compared with placebo group at 6 and 24 hours 
respectively.  There were no significant between-group differences in pain scores.  
There were no complications associated with any block.   
 
Ultrasound-guided transversus abdominis plane block is an effective addition to a 
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Part A: Research Protocol 
Efficacy of transversus abdominis plane blocks as part of a multimodal analgesia 
regime for total abdominal hysterectomies 
Principle investigator:  Dr Adri Marais 
Department of Anaesthesia 
Groote Schuur Hospital 
Trial coordinator:  Dr Owen Porrill   
Department of Anaesthesia 
Groote Schuur Hospital  
Index: 
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Patients that undergo a total abdominal hysterectomy experience significant 
postoperative pain. Multimodal pain regimes have been described to manage their 
pain.  Transversus abdominis plane (TAP) block has only recently been described 
(2001) as an addition or alternative to the other analgesic regimes. 
A limited number of studies have been done on TAP blocks and there is sufficient 
data to suggest that it shows a significant improvement in pain scores as well as 
morphine requirements postoperatively.  Many of the studies have been done with 
the landmark technique (blind “pop” technique via the Triangle of Petit).  Although 
there is minimal risk involved in administering the block, there is still a potential risk 
of bleeding, perforating abdominal organs or a failed block due to injecting the local 
anaesthetic in the wrong anatomical plane.  An ultrasound guided technique has 
been described to make the block safer and more reliable.  Less than 5 studies had 
been published by December 2010 on ultrasound-guided TAP blocks.  
The aim of our research is to study the efficacy of TAP blocks specifically in elective 
total abdominal hysterectomy (TAH) patients.  Only one randomised control trial has 
been published by December 2010 on using TAP blocks in total abdominal 
hysterectomies and in this trial the block was done with the landmark technique. 
We are aiming to do a small double-blind randomised control trial to demonstrate 
the efficacy of doing ultrasound-guided TAP blocks for total abdominal 
hysterectomies in improving patient pain postoperatively, as well as to decrease the 
morphine requirements.  This may assist recovery of patients and hopefully 
decrease emotional and psychological side-effects of major abdominal surgeries.    
Purpose of the Trial 
The objective of this trial is to study the efficacy of ultrasound-guided transverse 
abdominis plane (TAP) blocks in providing effective postoperative analgesia in 
patients undergoing elective total abdominal hysterectomy for benign disease. 
The primary aim is to measure morphine consumption and pain scores for 24 hours 
postoperatively.  Secondary aims include incidences of nausea, vomiting and 
pruritus. 
The null hypothesis is stating that ultrasound-guided TAP blocks do not provide 
enhanced postoperative pain relief for elective total abdominal hysterectomy 
8 
 
patients when used as part of a multimodal analgesic regimen. 
 
Background 
Patients that undergo a total abdominal hysterectomy experience significant post-
operative pain.  Multimodal pain regimes have been used.  The TAP block via the 
"Triangle of Petit" has only been described recently by Rafi [1] in 2001.  It provides 
enhanced pain control by blocking the sensory nerves that supply the anterior 
abdominal wall by injecting local anaesthetics in the plane between the abdominal 
muscles.  There is a fascial sheath between the internal oblique and transversus 
abdominis muscles.  The nerves lie deep to this fascia.  Following the work done by 
Rafi [1], Walter et al. [2] described a technique in 2008 where TAP blocks can be 
done with ultrasound imaging to make the procedure even more effective and safe.   
Because TAP blocks have only recently come into use, there is a limited amount of 
published literature.  A literature search was done using Pubmed and the Cochrane 
Collaboration with "TAP block" and "transversus abdominis plane block" as 
keywords.  All randomised controlled trials published by December 2010 were 
reviewed.   
Most of the studies were done on general abdominal surgery.  A meta-analysis on 
the clinical effectiveness of transversus abdominis plane blocks was published by 
Siddiqui et al. [3] in May 2010 where only four randomised controlled studies were 
discussed.  McDonnell et al.[4] established that the 24 hour post-operative morphine 
requirements in patients that underwent large bowel surgery with TAP blocks done 
with 0.375% levobupivacaine 20ml (10ml injected each side), was 70% less than in 
the control group without the TAP blocks.  They also published a randomised 
controlled trial in 2008 [5] that included patients undergoing a caesarean section.  
They monitored the cumulative morphine requirements for 48 hours postoperatively 
and reported that the group that had a TAP block required significantly less 
morphine than the control group.  
In 2009 El-Dawlatly et al.[6] showed that the morphine used by patients in the 24 
hours after laparoscopic cholecystectomy was significantly reduced by ultrasound-
guided TAP blocks done with 30ml 0,5% bupivacaine ( 15ml in each side).  More 
recently, in 2010, Ra et al. [7] also published a randomised controlled trial on the 
analgesic effect of the ultrasound-guided TAP block after laparoscopic 
cholecystectomies.  They showed that the intraoperative use of remifentanil, 
postoperative pain scores and the postoperative demand for rescue analgesia were 
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significantly reduced in the group that received a TAP bock with Levobupivacaine 
after induction of anaesthesia.  
There was only one other randomised controlled trial that was done with patients 
that had a total abdominal hysterectomy.  Carney et al.[8] published their trial in 
2008 after doing TAP blocks with 0.75% ropivacaine using the landmark technique.  
They showed that TAP blocks reduced postoperative pain scores as well as the 
mean total morphine requirement in the first 48 hours postoperatively.  
In all the above mentioned randomised control studies, the investigators made use 
of sham injections instead of local anaesthetics in the control group. No 
complications were reported by using these sham injections. 
 
Methodology 
1. Trial design 
To address the primary and secondary aims of our trial, we will be doing a double-
blind randomised controlled trial, using sham injections in the control group.  It has 
been shown to be a very low risk procedure when the TAP block is performed with 
the use of ultrasound guidance (no complications reported in the two studies that 
used ultrasound guided TAP blocks, El-Dawlatly et al. [6] and Ra et al. [7])  Patients 
will be randomised into two groups of 15 patients.  They will be randomly allocated 
to each group by using a sealed envelope technique.  The TAP block group will 
receive bilateral blocks with 0.25% bupivacaine after induction of anaesthesia.  In 
the placebo group the blocks will be done with normal saline.  In the placebo-group, 
injections of normal saline instead of 0.25% Bupivicaine will be administered by the 
investigator (who will be blinded to the specific group that the patient belongs to). 
The same standard of care regarding the administration of the blocks will be upheld 
in both trial groups and the safety of administration will be held to the highest 
standard.  It has been shown that a trial of this nature can be safely done in a 
double-blinded fashion.  To ensure that each patient gets the same standard of care 
and the TAP blocks are performed with uniform technical experience, only one 
anaesthetist will be performing each block on the patients, namely Dr Owen Porrill. 
To estimate the sample size needed to test the hypothesis with sufficient statistical 
power, we used the results from the trial done by McDonnell et al. [4] as proxy for 
our population group.  By using PASS 2008 (Hintze,J.(2008),Kaysville,Utah) we 
estimated that a group sample size of 9 patients in each group is needed to achieve 
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82% power to detect a difference of 3 points in the pain scores postoperatively. This 
was done with the assumption that the mean pain scores in the control group is 4.0 
and the mean pain score in the intervention group is 1.0 with known group standard 
deviations of 2.8 (control group) and 1.4 (intervention group) and with a significance 
level (alpha) of 0,05%.  A Mann-Whitney and a Student’s t-test will be used to 
analyse the final data, assuming that the actual distribution is uniform due to small 
sample size.  
Sample size estimation was also done by using the morphine requirements as 
guideline, also using the results from the trial done by McDonnell et al. [4] as proxy 
to our population group.  In this estimation group sample sizes of 15 in each group 
achieves 99% statistical power to detect a difference of 20mg morphine used in total 
after 24 hours postoperatively.  In the control groups the mean total dose was taken 
as 30mg and in the intervention group the mean was 10mg with known group 
standard deviations of 15,0mg (control group) and 10,0 (intervention group) and with 
a significance level (alpha) of 0,05% using a two-sided Mann-Whitney test assuming 
that the actual distribution is uniform. 
Considering the above sample size estimations, it was decided to recruit 15 patients 
to each group to incorporate a safety margin for errors.  
2. Characteristics of trial population 
Number of patients enrolled in the trial 
Thirty patients will be enrolled in total (15 patients in each group). 
Inclusion and exclusion criteria: 
Inclusion criteria:  Females booked for an elective total abdominal hysterectomy 
   ASA physical status 1-3 
    Adult patients between ages 20-65 
Exclusion criteria: Allergic to bupivacaine or morphine 
   History of opioid addiction 
 Any abdominal or gynaecological malignancy 
   Patients with coagulation disorders 
   Infection at the needle insertion site 
   Patient refuse to give informed consent to be part of the trial 




Children or mentally impaired adults will be excluded from the trial. 
Location of the research  
Patients that are booked on the elective gynaecology list at Groote Schuur 
Hospital will be approached and enrolled in the trial. 
3. Recruitment and Enrollment 
Patients will be recruited via convenience cluster sampling once they are booked on 
the elective gynaecology slate for a total abdominal hysterectomy not associated 
with any malignant process.  Patients will be identified the day before the surgery 
and they will be seen in the ward as part of their pre-operative assessment by the 
principle investigator.  If the patient qualifies for the trial, the details will be discussed 
with them.  The purpose, methods, effects and complications of the procedure will 
be explained to them, after which written informed consent will be obtained from 
them if they are willing to take part in the trial.  No commercial publication or 
advertisement will be used beforehand. 
4. Research Procedures and Data Collection Methods 
Both groups of patients will receive the same basic standard of care regarding the 
general anaesthetic and post-operative care.  A routine induction of general 
anaesthesia will be performed using the standard technique.  When vital signs are 
stabilized after endotracheal intubation, the TAP block will be performed by one 
skilled anaesthetist (Dr Owen Porrill) with the help of ultrasound guidance.  A 
SonoSite S-nerve ultrasound machine will be used in conjunction with Vygon 
Echoplex needles (100mm).  
The TAP block will be done as an aseptic procedure in the flank palpated between 
the 12th rib and the iliac crest.  The neuromuscular plane between the internal 
oblique muscle and the transversus abdominis muscle will be identified with 
ultrasound guidance.  The needle will be advanced by an ultrasound guided in-plane 
technique at the anterior axillary line.  The first “pop” sensation should be felt as the 
needle reaches the fascial plane between the external oblique and internal oblique 
muscles.  A second “pop” sensation should be felt as the needle enters the plane 
between the internal oblique muscle and the transversus abdominis muscle.  The 
exact location of the needle tip will be confirmed via direct ultrasound visualisation.  
After confirmation of the correct position of the needle and negative aspiration, 1-2 
ml of normal saline will be injected to identify position with water dissection.  After 
12 
 
confirmation of correct position the trial drug will be injected and spreading within the 
fascial layer will be confirmed on ultrasound.  A total of 20 ml will be injected on 
each side using the same technique. 
Each patient will receive a standardised post-operative analgesic regime, consisting 
of a morphine patient-controlled analgesia (PCA) pump, 100mg Indomethacin per 
rectum 12 hourly and 1g Paracetamol 6 hourly orally.  Rescue anti-emetics 
(Metoclopramide 10mg IVI/IMI) will be prescribed.  Patients will be followed-up 
immediately postoperatively in the recovery room, 6 hours and finally 24hours 
postoperatively.  The presence and severity of pain will be assessed using a visual 
analogue pain scale (VAS) and the total morphine requirements will be documented.  
Incidences of nausea, vomiting and pruritus will also be recorded.  
It is considered as standard post-operative care for patients undergoing a total 
abdominal hysterectomy to receive intramuscular morphine boluses 6 hourly as well 
as indomethacin and paracetamol.  Thus, the PCA pump that every patient will 
receive in this trial for at least the first 24 hours, is regarded as above standard care. 
The TAP blocks will be performed by Dr Owen Porrill, who is a consultant 
anaesthetist at the Department of Anaesthesia, University of Cape Town. He is 
experienced in doing peripheral nerve blocks with and without ultrasound guidance. 
The post-operative evaluation will be done by the principle investigator to exclude 
any observational bias during the evaluation process.  A senior anaesthetic registrar 
or consultant will be asked to prepare the trial drug in pre-marked syringes.  The 
syringes will be marked as the "study drug".  Due to the clarity of both solutions, it 
will not be able to discern the nature of the drug in the syringes.  The patients will 
randomly be allocated to be in the two groups. 
It will not be necessary to use any interpreters or other individuals in our trial. 
5. Data Safety and Monitoring Plan 
Performing a TAP block under ultrasound guidance is a very safe procedure.  There 
have been no complications recorded in the published randomised control trials 
where the block was performed under ultrasound guidance.  
If the block is performed without ultrasound guidance, there is potentially a higher 
risk of complications.  Complications that can occur are minor bleeding at the 
injection site, accidental intestinal puncture, unexpected diffusion of local 
anesthetics into additional body parts or even accidental liver puncture.  None of 
these complications are likely to be life-threatening or require intervention due to the 
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small caliber of the needle used.  Using ultrasound guidance reduces the risk of 
complications.  
The procedure will be performed under controlled and aseptic conditions in theatre 
while the patient will be monitored by the principal investigator and the trial 
coordinator for any complications.  The principle investigator will assess the patients 
directly postoperatively in the recovery room and will also personally follow-up the 
patients in the ward for monitoring purposes.  
If any unforeseen complication occurs in the ward, the principle investigator will be 
available to come and examine the patient, address and manage any problems. 
6. Data Analysis
Every patient’s data will be collected and recorded on a separate data sheet.  A 
number will be allocated to each patient and all data will remain anonymous.  The 
data will not include any personal or confidential information and will be stored in a 
secured locker in the anaesthetic department at Groote Schuur Hospital.  
Patients will be assessed immediately postoperatively as well as 6 hours and 24 
hours postoperatively.  Their total morphine requirements as well as their pain 
scores (using a visual analogue pain scale) will be documented.  A copy will be 
made of each patient’s completed data sheet and given to the trial coordinator to 
store securely in his office that is locked at all times in case any back-up information 
is needed. 
The plan for data analysis is to use a Student’s t-test and a Mann-Whitney U test. 
Description of Risks and Benefits 
Potential risks and discomforts 
There will be minimal risk involved participating in this trial.  The potential risks of 
complications of a TAP block (bowel perforation, liver perforation etc.) are minimised 
by doing the TAP block with ultrasound guidance.  The patients will be monitored 
closely intra-operatively and immediately postoperatively to make sure that no 
complication has occurred.  
There have been no recorded complications in any of the randomised control 
studies where TAP blocks were performed with ultrasound guidance.  None of the 
potential physical complications associated with this procedure is life-threatening 




The overall risk of the trial is minimal.  The risk involved is not more than doing a 
simple bedside procedure. 
Minimizing risk 
The block will be done with ultrasound guidance to avoid penetrating the peritoneum 
or puncturing any intra-abdominal organs.  Maldistribution of the local anaesthetics 
will also be avoided by confirming the position and distribution of the local 
anaesthetics under ultrasound visualisation. 
Potential benefits 
The patients will benefit from a standard of care that is regarded as above the 
normal analgesic post-operative management for a total abdominal hysterectomy, 
because each patient will receive a Morphine PCA pump.  This will ensure that 
staffing issues/problems in the wards will not cause delays in the patients receiving 
regular opioid analgesia.  
We are aiming to show that it is safe and effective to add a TAP block to the 
multimodal analgesic management of patients that undergo abdominal 
hysterectomy.  It is a feasible and easy option to provide most patients with an intra-
operative TAP block and we hope to prove that it improves their post-operative pain 
control. 
The technique of performing a TAP block is still a new concept, and the benefit of it 
must still be realised by anaesthetists as well as the surgeons that have to look after 
their patients postoperatively.  
The existing alternative routinely used as post-operative analgesia for these patients 
is regular intra-muscular morphine injections combined with other oral agents.  Due 
to frequent staff shortages and problems with the patient’s prescriptions, the patients 
often do not receive proper analgesia.  This causes severe discomfort and 
psychological stress among the patients and it delays their recovery after surgery. 
Harm: benefit ratio 
The benefit involved in doing the TAP block with ultrasound guidance outweighs the 






Informed Consent Process 
Process 
Informed consent will be taken from the patients during the pre-operative visit that 
will be done the previous day by the principle investigator.  
This process will take place in the ward after the patient has been admitted and the 
routine work-up is completed for her elective surgery.  After the pre-operative 
assessment has been performed, the patient will be evaluated to confirm that there 
are no contra-indications to her taking part in the trial.  If the patient qualifies, the 
goals and objectives, including all the pros and cons/possible side-effects of the trial 
will be discussed with the patient in private.  If the patient has any doubts or wants 
to discuss it with her family before giving consent, she will be able to so during the 
evening visiting hour.  The patient will then be seen pre-operatively the next day to 
confirm that she wants to continue being part of the trial. 
Capacity to consent 
Patients included in this trial must all be able to give informed consent.  Minors and 
mentally impaired patients will be disqualified.  If there is any doubt regarding a 
patient’s capacity to provide informed consent, the patient will not be included in the 
trial.  
Comprehension of information 
The trial will be explained to the participants in layman’s terms.  All the procedures 
and the pros/cons will be explained in detail.  Due to the simple nature of the 
procedure of performing a TAP block, it will be easy to explain all the detail in non-
medical terminology.  
The patients will be asked if they understand the information given to them.  They 
will be asked to explain the procedure in their own words at the end of process.  
Patients will be given a chance to ask questions during and after the process.  
Withholding information 
Due to the blinded nature of this trial, the patients will not be able to know whether 
they are in the bupivacaine or the placebo group.  All patients will be managed 
according to the same protocol.  All information and observations obtained during 






A consent form is formulated specifically for this trial.  
An adult consent form will be used in English.  It will not be translated into Afrikaans 
or any other South African language.  
Privacy and Confidentiality 
The data collected from the patients will not be of a private/personal nature.  The 
patient's name and date of birth will be recorded on a data sheet. A number will be 
assigned to each patient to ensure correct follow-up and identification of each 
patient.  
The data sheets will be stored in a locker in the anaesthetic department at Groote 
Schuur Hospital. The department is only accessible by an activated access card. A 
copy of all the data sheets will be kept in the trial supervisor’s office in the 
anaesthetic department that is locked at all times 
The datasheets will be converted to electronic format for statistical analysis.  The 
electronic data will be stored on a two separate flash drives.  Each flash drive will be 
kept locked away with the principal investigator and the supervisor as stated above.  
Data will be accessible by the investigator, the trial coordinator as well as the 
statistician that will assist with the statistical analysis at the end of the trial.  
Once the trial is completed and all statistical data is confirmed, the data will be kept 
for 12 months after the trial has been published to be available for any follow-up 
studies or any queries from peers.  
Reimbursement for Participation 
Patients taking part in the trial will not receive any compensation.  
Sponsorship/Budget 
The Western Cape branch of Viking Medical & Surgical Pharmaceuticals has agreed 
to sponsor the Morphine PCA pumps and Vygon echoplex needles that will be used 
in this trial.  They will not be involved directly in any aspect of this research and will 
have no influence on any of the results.   
What Happens at the End of a Trial? 
The goal of this trial is to provide knowledge to treatment of pain after elective 
hysterectomies.  The trial does not involve any investigatory drug or treatment that 
has to be continued after the first 24hours postoperatively.  
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At the end of the first 24 hours postoperatively, when the patients will exit the trial, 
the patients will continue on the routine postoperative analgesia regime.  Intra-
muscular opiates and oral Paracetamol will be prescribed to all the patients.  The 
primary surgical care will at no point be interrupted. 
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Part B: Literature review 
 
Objectives of literature review 
Patients who undergo a total abdominal hysterectomy (TAH) experience a 
significant amount of pain postoperatively.  Several multimodal pain regimes have 
been used in the past to manage these women’s pain.  Neuraxial anaesthesia is 
usually not a feasible option in these cases, because of the risks involved and 
limited resources with the lack of high care unit beds available.  Superior analgesia 
should include improved comfort with decreased side-effects by decreasing 
morphine requirements while allowing the patient to mobilise earlier. 
 
The aim of our research was to study the efficacy of transversus abdominis plane 
(TAP) blocks specifically in elective total abdominal hysterectomy (TAH) patients.  
This is a regional block that has only recently been described and is therefore still a 
relatively novel technique, especially if done with ultrasound guidance.  A limited 
amount of literature is available on the topic and the aim was to search for 
randomised controlled trials that included TAP blocks.  The literature was reviewed 
to identify the different block techniques that was utilised.  TAP blocks can be done 
blindly via the Triangle of Petit (landmark technique) or with ultrasound guidance. 
 
Several studies have been published where the analgesic use of TAP blocks have 
been investigated.  There is significant data to suggest that it causes an 
improvement in pain scores as well as morphine requirements postoperatively.  
Many of these studies were done with the landmark technique (also known as the 
blind “pop” technique via the Triangle of Petit).  The TAP block is generally a safe 
block, but there are potential complications, especially when using the blind 
technique.  There is a risk of bleeding, perforating abdominal organs or a failed 
block due to injecting the local anaesthetic in the wrong anatomical site.  An 
ultrasound guided technique has been described to make the block safer and more 
reliable. 
 
The TAP block provides enhanced pain control by blocking the peripheral nerves 
that provide sensory supply to the anterior abdominal wall from level T9-L1.  The 
nerves pass through the transversus abdominis plane in the fascial sheath between 
the internal oblique and transversus abdominis muscle in the lateral aspect of the 
abdominal wall between the costal margin and the iliac crest.  By identifying this 
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plane with ultrasound guidance, the needle tip can be visualised and real time 
spread of local anaesthetics can be confirmed.  TAP blocks have been studied in a 
number of contexts [1-17]. These studies have shown marked improvement in 
morphine requirements and pain scores by including a TAP block in the analgesia 
regime. 
 
Literature search strategy 
The objective of the literature review was to look at randomised controlled trials and 
meta-analyses published on the use TAP blocks during the past 10 years.  Trials 
that were published between January 2001 and December 2012 were included.  
 
The focus was on research that looked at treatment strategies for pain control in 
abdominal surgery patients.  The search was limited to randomised controlled trials 
and meta-analyses involving humans for abdominal surgery.  The population group 
included both adults and children.  The intervention was limited to TAP blocks, via 
the landmark technique and with ultrasound guidance.  The comparison could be 
with any other mode of analgesia, e.g. intrathecal morphine, subcutaneous wound 
infiltration or patient-controlled analgesia pumps.  The outcomes of the studies were 
assessed in regards to the statistical data as well as safety of the regional block and 
method of analgesia that was used in the control group.  
 
The electronic databases of the Health Sciences Library of The University of Cape 
Town were used to access MEDLINE, PUBMED and Cochrane library for the 
published articles.  The MeSH terms and text words used were “TAP blocks”, 
“transversus abdominis plane blocks” and “randomised controlled trial”.  Filters were 
used to include human trials, focusing on randomised controlled trials and meta-
analyses.  All age groups of patients were included in the search.  
 
Articles that were published in a language besides English were excluded.  
Research articles other than randomised controlled trials or meta-analyses were 
also excluded from the search.  If the electronic version of the full text of a relevant 
article could not be found with the online database, the University of Cape Town 
Library was used to find the printed versions.  The full text of all the articles was 




The literature search was limited to randomised controlled trials and meta-analysis 
that was published between January 2001 and December 2012.  These articles 
were critically reviewed to assess validity towards our proposed research.  The 
outcomes of the studies were assessed in regards to the statistical data as well as 
safety of the regional block and method of analgesia that was used in the control 
group.  
 
Summary and interpretation of literature, and its implications for the research 
TAP blocks have only recently come into fashion and therefore there is a limited 
amount of published randomised control trials on the subject.  
 
The TAP block via the "Triangle of Petit" was described by Rafi [1] in 2001.  It 
provides enhanced pain control by blocking the sensory nerves that supply the 
anterior abdominal wall by injecting local anaesthetics into the neurovascular plane 
between the abdominal muscles.  The transversus abdominis plane is a fascia 
sheath between the internal oblique and transversus abdominis muscles.  
 
The block was initially done by using a landmark technique through the Triangle of 
Petit.  The Triangle of Petit is superior to the iliac crest, between the latissimus dorsi 
and external abdominal oblique muscles.  A pop is felt when you pass the blunted 
needle through the fascia layer of the transversus abdominis muscle and the local 
anaesthetic is blindly deposited in this plane.  TAP blocks are generally a safe block 
to use, but there is potential for complications to occur, especially when this blind 
technique is used.  The potential complications could include extremes like liver 
trauma, as mentioned by Farooq et al. [2] in a case report.   
 
An ultrasound guided approach was discussed in a letter by Hebbard [3].  Walter et 
al. [4] continued with this idea and described a technique in 2008 where TAP blocks 






McDonnell et al.[5] established that the 24 hours post-op morphine requirements 
were significantly decreased in patients that had large bowel surgery with TAP 
blocks done with 0.375% levobupivacaine 20ml (10ml injected each side).  The 
morphine requirements in these patients were 70% less than in the control group.  
They continued their research in this field and published a follow-up randomised 
control trial in 2008 [6] with patients that had a caesarean section.  This was the first 
of many studies published looking at the use of TAP blocks for caesarean section 
patients.  They monitored the accumulative morphine requirements for 48 hours 
postoperatively and reported that the group that had a TAP block required less 
morphine.  The patients had lower pain scores and fewer opioid related side-effects 
than the control group.  In the TAP block group the women used less than a third of 
the morphine dose compared to the control.  
 
A meta-analysis on the clinical effectiveness of transversus abdominis plane blocks 
were published by Siddiqui et al. [7] in May 2010.  The analyses included four 
randomised control trials that were published between 2007 and 2009.  The 
respected studies were done on patient who received different types of intra-
abdominal surgeries.  Only one of these studies used ultrasound guidance for the 
TAP blocks.  The meta-analysis showed a significant difference in postoperative 
opioid requirement as well as time to first request for morphine.  The trial also had 
statistically significant decreases in pain scores, but only at 6 hours postoperatively 
and not for the rest of the observations.  They concluded that the TAP block offers 
comparable analgesia to opioids postoperatively and it reduces the morphine 
requirements while adding more effective pain relief.  They also concluded that it 
reduces side-effects associated with morphine or other opioids. 
 
In 2009 El-Dawlatly et al.[8] proved that the morphine used by patients 24 hours 
after they had a laparoscopic cholecystectomy was significantly reduced by doing 
ultrasound-guided TAP blocks.  The blocks were done with 30ml 0,5% bupivacaine ( 
15ml in each side).  More recently, in 2010, Ra et al. [9] also published a 
randomised control trial on the analgesic effect of the ultrasound-guided TAP block 
after laparoscopic cholecystectomies.  They showed that the intraoperative use of 
remifentanil, postoperative pain scores and the postoperative demand for rescue 
analgesia were drastically reduced in the group that received a TAP bock with 
Levobupivacaine after induction of anaesthesia 
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In 2009 Belavy et al. [10] also improved on the classic landmark technique by doing 
the blocks ultrasound guided for caesarean section patients.  They found that TAP 
blocks decreased morphine requirements by 40%.  In the same year Costello et al. 
[11] addressed the question of whether TAP blocks were an effective addition to 
intrathecal morphine analgesia.  They found that there was an initial improvement in 
post-op pain scores and morphine requirements, but after 12 hours there was 
minimal additional benefit to adding bilateral TAP blocks to intrathecal morphine 
anaesthesia.  Kanazi et al. [12] proved the same point by comparing ultrasound 
guided TAP blocks to 200ug intrathecal morphine for caesarean delivery. 
 
In 2011 McMMorrow et al. [13] and Loane et al.[14] confirmed the above findings 
that TAP blocks does not provide superior analgesia when compared to intrathecal 
morphine, but they did conclude that it was associated with fewer side-effects.  As in 
the above mentioned studies, the looked at the use of TAP blocks post caesarean 
section. 
 
 It is clear that ultrasound guided TAP blocks are safer and more reliable than the 
standard landmark technique.  McDermott et al. [15] had to terminate their trial early 
due to incorrect needle tip placement and intraperitoneal injection of up to 76% of 
their cases where the TAP blocks were done with the blind double “pop” technique. 
 
There are two other randomised control trials that were done with patients that had a 
total abdominal hysterectomy for benign disease.  Carney J et al. [16] published 
their trial in 2008 after doing TAP blocks with 0.75%ropivacaine by using the blind 
"pop" technique.  They concluded that the TAP block reduces postoperative pain 
scores as well as the mean total morphine requirement in the first 48 hours 
postoperatively.   
 
Atim et al. [17] also did a prospective, double-blind randomised controlled trial where 
they evaluated the efficacy of bilateral ultrasound guided TAP blocks compared with 
subcutaneous bupivacaine infiltration.  They only included patients that received a 
Pfannenstiel abdominal incision.  They found that both groups ( TAP block group 
and the group that received subcutaneous bupivacaine infiltration) had decreased 
pain scores compared to the control group, but the lowest scores were in the TAP 
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block group at 6 and 24 hours postop.  Post-op tramadol consumption rather than 
morphine consumption was compared between the groups in this trial.  The TAP 
block group again required less tramadol compared to the infiltration and control 
groups.  Both the infiltration and TAP block group however required rescue 
analgesia.  They concluded that ultrasound guided TAP blocks are superior to skin 
and subcutaneous bupivicaine infiltration. 
Identification of gaps or needs for further research 
This is still a relatively new and limited field.  Future research is needed to look at 
the complication and success rates.  Larger population groups are needed to study 
local anaesthetic dosing, toxicology of the different drugs used for this block as well 
as drug concentrations.  There is a need for training in doing this block, especially 
with using the ultrasound guided technique.  
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Summary 
Our aim with this double-blind randomised controlled trial was to study the efficacy 
of ultrasound-guided transversus abdominis plane blocks in patients undergoing 
total abdominal hysterectomy.  We randomly allocated thirty patients to two groups, 
a transversus abdominis plane block group (n=15) and a placebo group (n=15).  The 
transversus abdominis plane blocks were done with 0.25% bupivacaine.  The 
placebo group received a sham block with normal saline post induction of 
anaesthesia.  All patients received postoperative morphine patient-controlled 
analgesia.  Pain scores and morphine consumption were assessed at 0, 6 and 24 
hours postoperatively.  Our trial showed a significant between-group difference in 
morphine requirements (5.2±3.9 vs. 9.7±4.3 mg [p=0.007], and 12.9±8.9 mg vs. 
25±12.1 [p=0.006]) for the transversus abdominis plane- compared with placebo 
group at 6 and 24 hours respectively.  There were no significant between-group 
differences in pain scores.  There were no complications associated with any block.  
Ultrasound-guided transversus abdominis plane blocks are an effective addition to a 
multimodal postoperative analgesia regimen for abdominal hysterectomy.  
Introduction 
Patients who undergo a total abdominal hysterectomy (TAH) experience a 
significant amount of pain postoperatively.  Several multimodal pain regimes have 
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been used in the past.  Neuraxial anaesthesia is usually not a feasible option in 
these cases, because of the risks involved and limited resources in terms of 
postoperative high care beds.  Effective analgesia includes both improved comfort 
and decreased opiate side-effects, which should allow earlier mobilisation. 
 
A number of studies have investigated transversus abdominis plane (TAP) blocks 
after various abdominal surgical procedures, and there is data to suggest that it 
causes a significant improvement in pain scores as well as a reduction in 
postoperative morphine requirements [1].  Most of these studies were done with the 
landmark, or blind “pop” technique via the Triangle of Petit [2].  The TAP block is 
generally safe, but there are potential complications, particularly when using the 
blind technique.  Risks include bleeding, perforation of abdominal organs, or a failed 
block due to injecting the local anaesthetic in the wrong anatomical site.  An 
ultrasound-guided technique has been described to make the block safer and more 
reliable [3]. 
 
There are only two previous studies of TAP blocks for abdominal hysterectomy for 
benign disease.  The first employed the landmark technique, with its inherent 
limitations [4,5].  The second investigation used ultrasound guidance [5].  In the 
latter trial, only Pfannenstiel incisions were performed, and patient-controlled 
tramadol was administered, with pethidine as rescue in both groups.  In view of the 
paucity of available data on the efficacy of the TAP block post elective abdominal 
hysterectomy (TAH), we undertook a randomised double-blind controlled trial in 
patients receiving either Pfannenstiel or midline abdominal incisions.  We employed 
patient controlled IV morphine postoperatively, and examined the efficacy of TAP 
blocks in the reduction of morphine requirements and improvements in visual 
analogue pain (VAS) scores. 
    
Methods 
After approval from the University of Cape Town Human Research Ethics 
Committee, the trial was registered with the South African National Clinical Trial 
Register (DOH-27-0212-3945) and the South African National Human Research 
Ethics Council.  Data are presented in accordance with Consolidated Standards of 
Reporting Trials (CONSORT) statement.  We recruited thirty patients that were 
scheduled for elective total abdominal hysterectomy (TAH) for benign disease via 
Pfannenstiel or midline abdominal incision under general anaesthesia.  All patients 
between the ages of 20-65 with an ASA score I-III were included in a prospective 
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double-blind randomised controlled trial, after obtaining written informed consent on 
the day before the operation.  Patients were excluded if they were allergic to either 
of the trial medications (morphine, bupivacaine), had a history of opioid addiction, 
coagulation disorders, required surgery for malignant disease, or were unable to 
give informed consent.  During the preoperative visit, all patients received instruction 
concerning the function of their patient-controlled analgesia (PCA) pump.  In 
addition, the use of the visual analogue pain score (VAS) was explained.  The 
Universal Pain Assessment Tool was used.  The recruitment and explanations were 
performed by the same investigator in all cases (AM). The patients were randomised 
to two groups of 15.  Allocation was done by envelopes that had been sealed and 
shuffled.  Should any patient not proceed to TAH, the same envelope would be 
resealed and used for the next recruited patient.  The investigators would remain 
blind to its contents. 
 
After establishment of intravenous access in the operating theatre, routine 
monitoring was established, and patients received a standard general anaesthetic.  
The transversus abdominis plane (TAP) block group then received bilateral blocks 
with 20 ml 0.25% bupivacaine.  The placebo group received bilateral sham 
injections with 20 ml normal saline.  The principle investigator who recruited and 
evaluated the patients postoperatively, the trial coordinator, as well as the patients 
were blinded to the group allocations.  The trial drug was drawn up by an 
anaesthesiologist not involved in the trial.  All the blocks were done by a single 
anaesthetic consultant, who is experienced in ultrasound-guided blocks (OP).  An 
aseptic technique was used with an anterolateral approach to identify the external 
oblique, internal oblique and transversus abdominis muscles, and thus the 
transversus abdominis plane.  A SonoSite S-nerve  ultrasound machine with a linear 
array transducer probe was used (SonoSite, Inc., Bothell, WA98021, USA) .  The 
probe was placed superior to the iliac crest.  A Vygon echoplex needle was inserted 
and advanced (Viking Medical & Surgical [Pty] Ltd.).  The tip was identified with an 
in-plane technique until it reached the transversus abdominis plane.  After negative 
aspiration, 1-2 ml sterile water was injected to confirm the plane with hydro 
dissection.  The trial drug was then slowly injected under real-time ultrasound 
imaging (visualising the spread of the trial drug).  The same process was repeated 
on the opposite side, after which the patient was prepared for surgery and the 
operation commenced. 
 
The conduct of the general anaesthetic was at the discretion of the attending 
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anaesthesiologist.  Intraoperative opioid and anti-emetic use were not part of our 
trial protocol.  The patients in placebo group received on average 1,5 ug/kg of 
fentanyl and 0,08 mg/kg of morphine.  The patients in the TAP block group received 
on average 1,4 ug/kg of fentanyl and 0,1 mg/kg of morphine.  A standard 
postoperative multimodal analgesia regime was prescribed.  Patients received 
paracetamol 1g 6 hourly per os, indomethacin 100 mg 12 hourly per rectum, and an 
anti-emetic (prochlorperazine 12.5 mg intramuscularly) as needed.  Each patient 
received morphine via a patient-controlled analgesia (PCA) pump.  A Vygon 
Freedom 5 disposable PCA device (Viking Medical & Surgical [Pty] Ltd.) was used 
with morphine 1 mg/ml and droperidol 0.1 mg/ml boluses with a 7 min lock-out time. 
The PCA pump was connected to a dedicated intravenous line. 
Patients were taken to the recovery room after the operation where the baseline 
assessment was done.  Thereafter they were discharged to the gynaecology ward, 
where they were assessed by the same investigator at 6 and 24 hours 
postoperatively.  Primary outcome variables were morphine requirements and pain 
scores.  Morphine requirements were assessed by inspecting the PCA pumps.  A 
visual analogue pain scale was used to assess their pain at rest as well as with 
movement.  Secondary outcomes (nausea, vomiting and pruritis) were also 
assessed by direct questioning.  Lastly, a note was made with every assessment as 
to whether the patients received the pain regimen as prescribed in the ward. 
The Null hypothesis was that ultrasound-guided TAP blocks do not provide 
enhanced postoperative pain relief for elective total abdominal hysterectomy 
patients, when used as part of a multimodal analgesia regimen.  To estimate the 
sample size needed to test this hypothesis with sufficient statistical power, we used 
the results from the trial done by McDonnell et al. [6] as proxy to our population 
group.  By using the software programme PASS 2008 (Hintze, J. [2008].PASS, 
Kaysville, Utah), we estimated that a group sample size of 9 patients in each group 
would be needed to achieve 82% power to detect a difference of 3 points in the 
postoperative pain scores.  This was done with the assumption that the mean pain 
scores in the control group would be 4.0 and the mean pain score in the intervention 
group would be 1.0, with known group standard deviations of 2.8 (control group) and 
1.4 (intervention group), and with a significance level (alpha) of 0,05%.  Sample size 
estimation was also done by using the morphine requirements as a guideline, using 
the results from the same trial.  In this estimation group sample sizes of 5 in each 
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group would be needed to achieve 85% statistical power to detect a difference of 30 
mg morphine used in total after 24 hours postoperatively.  In the control groups, the 
mean total dose was taken as 40 mg and in the intervention group the mean was 10 
mg, with known group standard deviations of 20 mg (control group) and 10 mg 
(intervention group) and with a significance level (alpha) of 0,05% using a two-sided 
Mann-Whitney U test, assuming that the actual distribution is uniform.  Considering 
the above sample size estimations, it was decided to recruit 15 patients in each 
group to incorporate a safety margin for errors.  Statistical analyses were performed 
using Statistica Version 10 (StatSoft, Inc. [2011].STATISTICA, version 10).  The 
continuous data (postoperative morphine consumption and pain scores) were 
analysed by using Student’s t-test.  Student’s t-test as well as Mann-Whitney U tests 
were used to compare postoperative pain scores.  The descriptive statistics are 
reported by their mean results and standard deviation.  A p value<0.05 was 
considered statistically significant. 
 
Results 
Thirty patients were randomly allocated to 2 groups of 15.  One patient in the TAP 
block group was excluded from the trial after the 6 hour postoperative observation, 
because she had intra-abdominal bleeding requiring surgical re-exploration.  This 
was unrelated to the TAP block.  Another patient in the TAP block group had to be 
excluded from the 24 hour observation, because the morphine PCA pump was 
accidentally removed during the night.  So, the final analysis included 14 patients in 
the TAP block group for the 6 hour analysis and 13 patients for the 24 hour analysis.  
The placebo group consisted of 15 patients for all the postoperative analyses. 
 
The demographics of the two groups were similar.  The patients' age, height, weight 
and body-mass index were compared and no significant differences were noted 
(Table 1). 
 
There was a significant between-group difference in morphine requirements 
(5.2±3.9 vs. 9.7±4.3 mg [p=0.007], and 12.9±8.9 mg vs. 25±12.1[p=0.006]) for the 
TAP block compared with the placebo group at 6 and 24 hours respectively (Table 2, 
Figures 1 and 2).  There were no significant between-group differences in pain 
scores at rest or on movement (Table 3).  There were no complications associated 
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with any block.   
 
Four patients (two in the placebo- and two in the TAP block group) complained of 
nausea, but none of them required rescue anti-emetics.  Three of these patients 
complained of the nausea in the recovery room directly after their operation.  None 
of the patients complained about pruritus on direct questioning. 
 
Discussion 
We did a prospective double-blind randomised control trial to evaluate whether 
bilateral ultrasound-guided TAP blocks improve postoperative pain and decrease 
morphine requirements in patients undergoing elective TAH.  Our trial showed that 
ultrasound-guided TAP blocks significantly reduce postoperative morphine 
requirements compared with placebo.  The mean morphine requirements in the TAP 
block group decreased by 47% at 6 hours (5.2±3.9 vs. 9.7±4.3 mg [p=0.007]) 
and by 49% at 24 hours postoperatively (12.9±8.9 mg vs. 25±12.1[p=0.006]).  
This was despite the fact that, by chance, the TAP block group had more patients 
with midline incisions.  In the placebo group 2 patients compared to 8 patients in the 
TAP block group had midline incision. 
 
Due to the effective use of patient-controlled IV analgesia, there was no significant 
between-group difference in pain scores.  There was a low incidence of nausea, but 
the trial was not powered to detect differences in side effects.  There were no 
complications related to the TAP block. 
 
The TAP block via the so-called "triangle of Petit" was described by Rafi [2] in 2001.  
It provides enhanced pain control by blocking the peripheral nerves that provide 
sensory supply to the anterior abdominal wall from level T9-L1.  The nerves pass 
through the transversus abdominis plane in the fascial sheath between the internal 
oblique and transversus abdominis muscles in the lateral aspect of the abdominal 
wall between the costal margin and the iliac crest.  By identifying this plane with 
ultrasound the needle tip can be seen and real time spread of local anaesthetics can 
be confirmed.  TAP blocks have been studied in a number of contexts, including 
limited data post TAH [1].  These studies have shown marked reduction in morphine 
requirements by including a TAP block in the analgesia regimen. 
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There are two other randomised controlled trials employing TAP blocks for total 
abdominal hysterectomy for benign disease.  Carney et al. [4] used 0.75% 
ropivacaine in the the blind "pop" technique.  They showed a reduction in 
postoperative pain scores as well as the mean total morphine requirement in the first 
48 hours postoperatively.  It is clear that ultrasound-guided TAP blocks are safer and 
more reliable than the standard landmark technique.  McDermott et al. [7] had to 
terminate their trial early due to incorrect needle tip placement and intraperitoneal 
injection in 76% of their cases where TAP blocks were done with the double “pop” 
technique.  In 2009 Belavy et al. [8] improved on the classic landmark technique by 
doing the blocks with ultrasound guidance for caesarean section.  They found that 
TAP blocks were associated with a 40% reduction in morphine requirements.  A 
recent editorial calls for the use of ultrasound guidance as standard of care for TAP 
blocks during caesarean section [9]. 
Atim et al. [5] performed a prospective, double-blind randomised controlled trial in 
which they evaluated the efficacy of bilateral ultrasound-guided TAP blocks for TAH, 
compared with subcutaneous bupivacaine infiltration.  They found that both groups 
had decreased pain scores compared to a control group, but the lowest scores were 
found in the TAP block group at 6 and 24 hours.  Post-operative tramadol 
consumption was compared between the groups.  The TAP block group also 
required less tramadol compared to the infiltration and control groups.  Both the 
infiltration and TAP block group however required rescue analgesia.  They 
concluded that ultrasound-guided TAP blocks are superior to skin and subcutaneous 
bupivacaine infiltration.  Our trial is only the second to employ ultrasound-guided 
TAP block for post-hysterectomy pain relief, and differs from the previous trial in that 
patients with midline and Pfannenstiel incisions were included, and postoperative 
morphine consumption was studied as part of a multimodal analgesic regimen. 
Limitations of our trial include the fact that it was not powered to assess differences 
in opioid related side effects.  The type of surgical incision was not standardized, 
that is, patients with midline and Pfannenstiel incisions were included.  Another 
limitation to our trial is that it was not powered to assess for safety or reliability due 
to the small sample size.  The issue of potential local anaesthetic toxicity was not 
specifically addressed, but all doses were within the recommended range.  We only 
assessed patients for the first 24 hours, and although it has been suggested that 
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TAP blocks are beneficial even after  after 48 hours 4,10, we did not extend our 
monitoring period, due to limited time resources. 
We observed that the pain scores in the two groups did not differ, but we did show a 
marked decrease in morphine requirements between the groups.  Another limitation 
to our trial is that we did not evaluate sedation scores, because this would arguably 
have shown that the patients who required more morphine would have been more 
sedated.  This in turn can potentially hamper early mobilisation and therefore 
recovery and time to discharge.  The clinical relevance of introducing a TAP block 
for these patients would be including a regional technique with minimal risks with no 
added discomfort to the patient and the benefit of comfort without the requirement of 
excess morphine postoperatively. 
The final outcome of this trial is that the performance of bilateral ultrasound-guided 
TAP blocks in women undergoing TAH is a useful addition to a multimodal analgesia 
regimen, resulting in a significant reduction in postoperative morphine requirements. 
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Table 1: Patient demographics.  Values are mean and standard deviation (SD). 
Mean (SD) Mean(SD) 
Placebo TAP 
Age (years) 48 (6.7) 46.6 (4.7) 
Height 
(meter) 
1.63 (0.06) 1.62 (0.04) 
Weight (kg) 74.4 (17.8) 65.8 (12.4) 
BMI (kg.m-2) 27.9 (6.6) 25 (5.3) 
Table 2: Postoperative Morphine consumption.  Values are mean, p value and 
standard deviation (SD) 
Mean Mean p SD SD 
Placebo TAP Placebo TAP 
M6 (mg) 9.7 5.2 0.007 4.3 3.9 
M24 (mg) 25 12.9 0.006 12.1 8.9 
M6 = Morphine consumption at 6 hours; M24 = Morphine consumption at 24 hours 
Table 3: Pain scores: Student’s t-test.  Values are mean and p values. 
Mean Mean p 
Placebo TAP 
Pain Rest 0 4.2 4.3 0.87 
Pain Movement 0 4.6 4.9 0.75 
Pain Rest 6 2.4 2.3 0.87 
Pain Movement 6 2.8 2.8 0.98 
Pain Rest 24 1.4 1.1 0.61 
Pain Movement 24 2.0 1.4 0.18 
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a. Consent form
INFORMED CONSENT FORM 
Informed Consent Form for women who will undergo an elective total abdominal 
hysterectomy (not related to any malignancies) and who we are inviting to participate 
in a research trial investigating the beneficial role of transversus abdominis plane 
blocks inserted with ultrasound guidance in post-operative pain control.  
Name of Principal Investigator : Dr Adri Marais/Dr Owen Porrill 
Name of Institution : University of Cape Town 
This informed consent has two parts: 
. Information sheet (to share information about the trial with you) 
. Certificate of consent (for signatures if you choose to participate) 
You will be given a copy of the full Informed Consent Form (ICF) 
Part 1 :  Information Sheet 
Introduction 
I am Dr Adri Marais, working at Groote Schuur Hospital in the Anaesthetic 
Department. I am doing a trial to see if we can help to relieve your pain after your 
operation. We are planning to use a small injection on either side of your stomach 
after you are asleep in theatre.I am going to give you more information and ask you 
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to be part of this trial. You can talk to anyone you would like, before making any 
decision about participating. This form may have words that you do not understand. 
You can ask me to explain anything as I read the form with you. 
 
Purpose of the Research 
Pain relief in women who have had a total abdominal hysterectomy (the operation 
that you are going to have) can be difficult, especially in the first 24 hours after the 
operation. The medicine that we currently use is regular pain injection (morphine) 
and other pain tablets. We would like to know if your pain can be better controlled   if 
we block the nerves in the front part of your stomach. We know that these nerves 
are the most important nerves involved in the pain after the operation. We would 
also like to see if women who have received this block would need less pain 
injections after the operation and therefore have less bad effects of too much 
morphine, eg nausea, skin itchiness and sleepiness.  
 
Type of Research Intervention 
This trial involves doing the two injections, called a transversus abdominis plane 
block, after you have already been put to sleep by the anaesthetist in theatre. This 
will be a double-blind randomised controlled trial, which means that half the patients 
will receive the real injection and the other half will receive a injections with water. 
We, the docters will not know which patients received the real of the fake injection 
so that we can treat everyone the same. I will come to see how you are doing in the 
ward for the first 24 hours after your operation. I will visit you 6 hours and 24 hours 
after your operation to see if you have pain or not. 
 
Participant Selection 
You have been invited to take part in this trial because you are on the operation list 
to have your womb removed tomorrow.You can help us to improve our services to 
you and other women who have the same operation in the future. 
 
Voluntary participation 
Your participation is entirely voluntary. It is your choice whether to take part in the 
trial or not.  If you choose not to take part, all the treatment you would normally have 
received at this hospital will continue and nothing will change. 
Procedures  
The injections will be done under clean conditions by an experienced anaesthetist 
with an ultrasound machine to make sure we give the injection in the right place. 
39 
The injections will be done with a drug called Bupivicaine (we use it for similar 
injections every day) or with clean water. We will inject the medicine/water in both 
sides of your lower stomach wall between two layers of muscles under your skin 
(not into your abdominal cavity). 
Everyone will be given a routine and safe anaesthetic (no different to any other 
general anesthetic). You will be given morphine and other pain medication 
throughout the operation, as usual. We will wake you up immediately after the 
operation. 
After the operation you will be given a morphine pump with which you can give your 
own pain medication. We will show you how to use it before and after the operation. 
This pump will make sure that you do not have to wait for a sister to come and give 
you pain medicine. We do not usually give patients a morphine pump after this kind 
of operation, because it is too expensive. 
I will come so see you once you are awake after your operation to make sure you do 
not have any pain. I will also come and visit you in the ward just before I go home in 
the afternoon ( 6 hours after your operation) and one last time the next day (24hours 
after your operation). I will also ask you if you had any complaints of bad effects due 
to the morphine,eg nausea, sleepiness and itchy skin. If the injections in your 
stomach wall are as successful as we are hoping it to be, you will not need nearly as 
much other pain medicine to control your pain.  
Duration 
The trial will take place over the first 24 hours after your operation. During and after 
that, you will receive normal care by the docters that will be doing your operation.  
Risks 
The injections are very easy and safe to do. You will already be asleep by then. In 
some of the other studies that looked at the same injections they found that there is 
a small chance of bleeding or infection. At the worst the needle might go into the 
stomach instead of just in the stomach wall. We will be doing the injections with the 
help of a ultrasound machine so that we can see where we put the injections and 
make sure that it does not go through the stomach wall. We will clean your skin well 
before we do any injection. 
 Benefits 
If you take part in the trial it will help us to find out if we can start to give every 
patient these injections if they have similar big operations. It will help to prove that 
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your pain is better controlled after the operation and that less morphine is needed. 
All of this may speed up your recovery.  
During the trial you will also receive a better standard of care, because patients do 
not usually receive a morphine pump after an operation like yours. That will make 
sure that you are more comfortable and pain free.  
 
Reimbursements 
You will not be given any money for taking part in this trial. 
 
Confidentiality 
None of the information that we need in this trial is personal in nature. The 
information that we collect from this trial will be kept safe and private. We will not 
share any information about you with anyone outside the trial team. 
 
Sharing the Results 
The knowledge that we get from the results of the trial will be shared and published, 
so that other docters may learn from the findings of the trial. Your name will not be 
mentioned anywhere.  
 
Right to Refuse or Withdraw 
You do not have to take part in this trial if you do not want to and may withdraw from 
the trial at any time. Whether you choose to take part or not, your decision will not 
make any difference to the treatment that you will receive from me or the docters 
that will be doing your operation. 
 
Who to Contact 
 
If you have any questions, you can ask them now or later. If you wish to ask 
questions later you can contact me in any of the following ways below: 
Name          : Dr Adri Marais          
Telephone   : 0000000000 







Part 2 : Certificate of Consent 
I have been invited to take part in a trial to see if injections around the nerves in my 
stomach wall (transversus abdominis plane block) can help to make the pain after my 
operation better. 
I have read everything on this form with the docter. I have had the chance to ask 
questions about it and any questions I have been asked have been answered so that I 
can understand everything.  
I am willing to be part of this trial. 
Print Name of Participant     __________________ 
Signature of Participant  ___________________ 
Date __________________ 
 Day/month/year 
Signature of witness      _______________ 
Date ________________________ 
       Day/month/year 
Statement by the researcher/person taking consent: 
I have accurately read out the information sheet to the potential participant, and to 
the best of my ability made sure that the participant understands that the following will be 
done: 
1. The participants treatment will not change whether she does or does not
take part in the trial.
2. All information  will be kept private and locked away.
3. She can withdraw from the trial at any time during the research.
I confirm that the participant was given an opportunity to ask questions about the 
trial, and all the questions asked by the participant have been answered correctly and to 
the best of my ability. I confirm that the individual has not been coerced into giving 
consent, and the consent has been given freely and voluntarily.  
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A copy of this ICF has been provided to the participant. 
Print Name of Researcher/person taking the consent________________________ 
Date ___________________________ 
 Day/month/year 
b. Example of search criteria conducted as part of the literature review
The electronic databases of the Health Sciences Library of The University of
Cape Town were used to access MEDLINE, PUBMED and Cochrane library
for the published articles.  The MeSH terms and text words used were “TAP
blocks”, “transversus abdominis plane blocks” and “randomised controlled
trial”.  Filters were used to include human trials, focusing on randomised
controlled trials and meta-analyses.  All age groups of patients were included
in the search.
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c. Official Ethics approval letter from the Faculty Research Ethics Committee
Please see the approval letter below. Please be advised that my name 
changed from Adri Troskie to Adri Marais. Please see marriage certificate 
attached 
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d. Annual progress report: Human Research Ethics Committee
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e. Marriage certificate:
